Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
He has bought shares moving his holding from 16% up to over 17.2%
I have asked the company but this link suggests it is an area of interest so look on http://quetzalcapital.co.uk/ and you will see in the opening statement the type of companies that they are seeking to invest in.
OO core at 20p is trading on a PE of 40 based on finnCap forecast eps for FY22, which is due for release in Mar23! Putting the shares on a more realistic PE of 20, based on achieving good double digit eps growth going forward, the OO core shares would be 10p. To achieve this growth with facilities already near 100% utilised the charges for new contracts would have to rise significantly above any cost increases or they could add new facitilities at negligible cost and fully utilise them. We can add 9p for spin-offs and 2p cash and get a short term valuation of 21p. Post spin offs this drops to 10p core +2p cash. So, OO will need to come in with much better eps than forecast to merit a rise in SP. However CF has hinted at a merger post spin offs to achieve a US listing and he is looking to 3x his investment (by selling off the co?) - that would be 80p based on last purchase. Contract news is important to confirm ongoing facility usage. Corporate activity is key though for SP.
I have seen on RNS some minor reductions in the holdings of Monecor, Mahtani and Patel in the last few months. http://quetzalcapital.co.uk/
Monecor holding increased to 13.016% on 28th Sept.
CF did say that future spin offs would not have a lock-in. DIM will be different to Poolbeg. One of the others may actually be sold.
The 100,000 probably was a sell and the 30k,10k and 60k were actually buys (put on LSE as sales). I bought some!
They are still looking for right deal and unlike AIM there appears to be no time limit on Aquis. Email on the co website.
finnCap downgraded their valuation from 47 to 44p. They have negative eps for FY21 and on their forecast for FY 22 OO are on a PE of 52x. Not sure what justifies that rating but obviously the spin offs will add to the value within their valuation. Corporate activity is also an unknown. I await the presentation.
Does this SPAC have to have an RTO ready by beginning of October to meet 6 month rule?
Half Year results discussion at 4.30pm 12th Oct
Deepjoy - surely 1.4p eps on a 20p SP gives PE of 14.3. If you did apply 30x PE as acceptible (Ricky) the SP would be 21p+10p+3p=34p (based on adding non-core value and cash value to core from FinnCap note). Revenue multiple valuations are only used for loss making cos that are growing rapidly but we are told this is profitable.
The only announcement from the BoD will be ADMINISTRATION due to the losses after the failed RTO. Iclaprim is held elsewhere now and administration would end any potential value to Motif shareholders. Gold wants an end to this situation and will retain his reputation by blaming shareholders for voting down his wonderful RTO. Any other outcome can only be achieved by joining the SHAREHOLDERS group to have your say and a vote.
Could we see institutional buying coming in over the next month using OO as a cheap way into DIM?
I believe the ratio was amended to 1 for every 2.98154465.
I have at last seen FinCap note. If I apply 20PE to 0.6adj eps forecast (Dec 21) I get 12p OO core (cf 34p Fincap unexplained) + 10p non-core + 3p cash (their figures) = 25p. Should the eps come in 1.2p say we get 37p (FinCap 47p). Also the value of the floats could be different. Trouble is the full results aren't out until June 2022.
Of course we do not know the growth rate of the core going forward other than it may be an income stock with possibly high teens growth (?) following the recovery from losses. The next news is a presentation Q&A ON 9th Aug on Investor Dashboard. Maybe Vox too and more contracts (?) Then DIM possibly demerger early September, which will hopefully attract some Institutions. The interims are also due in Sept.
Short term there is obviously a large seller or two depressing the price. I would be interested to know the top ten holdings now, as a list I got off Marketscreener.com has Acacia Research as the largest holder at 5.76% and Cathal at 3.21% so clearly out of date but there are a half dozen institutions on the list.
You can carry on being negative on a share chat site where possibly half the people aren't even shareholders. Then the very likely outcome is the company goes into administration and the end of Iclaprim proceeds (if any). Or you could join the many in the Shareholder Action Group who have all had to prove they are shareholders and with decent leadership. Your choice!
Could they be shorting the shares?
To find out what is happening:-
"Please join by sending confirmation of your shareholdings screenshots and email…
Alanclarke1000@hotmail.com
You will be then be linked to the Telegram shareholders action group."
Many thanks Scooby and Oasis for your help.
Does anyone have a link to Arden research?
As mentioned many times on here, send a screenshot of your holding to:- Alanclarke1000@hotmail.com